Aurobindo Pharma, Sandoz Terminate U.S. Dermatology, Oral Solid Businesses Deal
Syringes make their way though a machine. (Photographer: Jim R. Bounds/Bloomberg)

Aurobindo Pharma, Sandoz Terminate U.S. Dermatology, Oral Solid Businesses Deal

Aurobindo Pharma Ltd. said it reached a mutual agreement with Sandoz Inc. to terminate the deal to acquire the Novartis AG subsidiary's generic oral solids and dermatology businesses in the U.S.The...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.